Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to “simplify its (company’s) dermatology ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

In this article, we are going to take a look at where Hims & Hers Health ... Sales of high-end products surged by 12%, while sales of body sprays and hair fragrances jumped by 94% and 32%.

Pricing for Hims ED products will vary depending on your dosage and if you order from the website or have the prescription sent to another pharmacy. Costs will range from a few dollars per pill to ...

Body care products, such as lotions ... beating its benchmark by 218 percentage points (see more details here). Hims & Hers Health, Inc. (NYSE:HIMS) is a multi-specialty telehealth platform ...